Psychemedics Income from Continuous Operations 2010-2024 | PMD

Psychemedics income from continuous operations from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Psychemedics Annual Income from Continuous Operations
(Millions of US $)
2023 $-4
2022 $-1
2021 $-1
2020 $-4
2019 $2
2018 $5
2017 $6
2016 $7
2015 $2
2014 $3
2013 $4
2012 $3
2011 $3
2010 $3
2009 $2
Psychemedics Quarterly Income from Continuous Operations
(Millions of US $)
2024-09-30 $-1
2024-06-30 $-1
2024-03-31 $-1
2023-12-31 $-1
2023-09-30 $-2
2023-06-30 $-1
2023-03-31 $-0
2022-12-31 $-1
2022-09-30 $-0
2022-06-30 $-0
2022-03-31 $0
2021-12-31 $-2
2021-09-30 $1
2021-06-30 $0
2021-03-31 $0
2020-12-31 $-1
2020-09-30 $-1
2020-06-30 $-2
2020-03-31 $-0
2019-12-31 $-1
2019-09-30 $1
2019-06-30 $1
2019-03-31 $1
2018-12-31 $1
2018-09-30 $1
2018-06-30 $1
2018-03-31 $1
2017-12-31 $2
2017-09-30 $1
2017-06-30 $1
2017-03-31 $2
2016-12-31 $2
2016-09-30 $3
2016-06-30 $2
2016-03-31 $-0
2015-12-31 $0
2015-09-30 $1
2015-06-30 $0
2015-03-31 $0
2014-12-31 $1
2014-09-30 $1
2014-06-30 $1
2014-03-31 $1
2013-12-31 $1
2013-09-30 $1
2013-06-30 $1
2013-03-31 $1
2012-12-31 $0
2012-09-30 $1
2012-06-30 $1
2012-03-31 $1
2011-12-31 $0
2011-09-30 $1
2011-06-30 $1
2011-03-31 $1
2010-12-31 $0
2010-09-30 $1
2010-06-30 $1
2010-03-31 $1
2009-12-31 $1
2009-09-30 $1
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.703B 0.00
Quest Diagnostics (DGX) United States $17.349B 17.58
DaVita (DVA) United States $14.249B 18.43
Encompass Health (EHC) United States $9.629B 22.70
Chemed (CHE) United States $8.394B 25.80
Elanco Animal Health (ELAN) United States $6.076B 14.46
Option Care Health (OPCH) United States $5.267B 24.96
RadNet (RDNT) United States $4.972B 110.11
LifeStance Health (LFST) United States $3.092B 0.00
Amedisys (AMED) United States $3.023B 21.51
Addus HomeCare (ADUS) United States $2.290B 26.87
Astrana Health (ASTH) United States $2.076B 28.39
U.S Physical Therapy (USPH) United States $1.337B 35.14
Pennant (PNTG) United States $0.945B 38.21
Aveanna Healthcare Holdings (AVAH) United States $0.945B 0.00
Atai Life Sciences (ATAI) Germany $0.252B 0.00
Bioqual (BIOQ) United States $0.055B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00